Innohep (BioDeep_00000841824)
代谢物信息卡片
Innohep
化学式: Sn+4 (119.902199)
中文名称:
谱图信息:
最多检出来源 () 0%
分子结构信息
SMILES: [Sn+4]
InChI: InChI=1S/Sn/q+4
描述信息
D006401 - Hematologic Agents > D005343 - Fibrinolytic Agents
D006401 - Hematologic Agents > D000925 - Anticoagulants
D050299 - Fibrin Modulating Agents
D002317 - Cardiovascular Agents
同义名列表
1 个代谢物同义名
相关代谢途径
Reactome(0)
BioCyc(0)
PlantCyc(0)
代谢反应
0 个相关的代谢反应过程信息。
Reactome(0)
BioCyc(0)
WikiPathways(0)
Plant Reactome(0)
INOH(0)
PlantCyc(0)
COVID-19 Disease Map(0)
PathBank(0)
PharmGKB(0)
0 个相关的物种来源信息
在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有：
- PubMed: 来源于PubMed文献库中的文献信息，我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表，这个列表按照代谢物同时出现的文献数量降序排序，取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
- NCBI Taxonomy: 通过文献数据挖掘，得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序，取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
- Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
- Chemical Reaction: 在化学反应过程中，存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。
点击图上的相关代谢物的名称，可以跳转到相关代谢物的信息页面。
文献列表
- Karolina Akinosoglou, Christos Savopoulos, Abraham Pouliakis, Charalampos Triantafyllidis, Eleftherios Markatis, Foteini Golemi, Angelos Liontos, Charikleia Vadala, Ilias C Papanikolaou, Vasiliki Dimakopoulou, Panagiotis Xarras, Katerina Varela, Georgia Kaiafa, Athanasios Mitsianis, Anastasia Chatzistamati, Efthalia Randou, Spyridon Savvanis, Maria Pavlaki, Georgios Efraimidis, Vasileios Samaras, Dimitrios Papazoglou, Alexandra Konstantinidou, Periklis Panagopoulos, Haralampos Milionis, On Behalf Of The Interact Study Group. Intensive-Dose Tinzaparin in Hospitalized COVID-19 Patients: The INTERACT Study.
Viruses.
2022 04; 14(4):. doi:
10.3390/v14040767. [PMID: 35458497] - Sandra Jonmarker, Jacob Hollenberg, Martin Dahlberg, Otto Stackelberg, Jacob Litorell, Åsa H Everhov, Hans Järnbert-Pettersson, Mårten Söderberg, Jonathan Grip, Anna Schandl, Mattias Günther, Maria Cronhjort. Dosing of thromboprophylaxis and mortality in critically ill COVID-19 patients.
Critical care (London, England).
2020 11; 24(1):653. doi:
10.1186/s13054-020-03375-7. [PMID: 33225952] - Ruhaid Khurram, Franklin T F Johnson, Revati Naran, Samanjit Hare. Spontaneous tension pneumothorax and acute pulmonary emboli in a patient with COVID-19 infection.
BMJ case reports.
2020 Aug; 13(8):. doi:
10.1136/bcr-2020-237475. [PMID: 32784238] - Renée Brüggemann, Hester Gietema, Borefore Jallah, Hugo Ten Cate, Coen Stehouwer, Bart Spaetgens. Arterial and venous thromboembolic disease in a patient with COVID-19: A case report.
Thrombosis research.
2020 07; 191(?):153-155. doi:
10.1016/j.thromres.2020.04.046. [PMID: 32386986] - Hélène Helfer, Virginie Siguret, Isabelle Mahé. Tinzaparin Sodium Pharmacokinetics in Patients with Chronic Kidney Disease: Practical Implications.
American journal of cardiovascular drugs : drugs, devices, and other interventions.
2020 Jun; 20(3):223-228. doi:
10.1007/s40256-019-00382-0. [PMID: 31721053] - D Projean, S Lalonde, J Morin, E Nogues, A Séguin, A Vincent, J P Lafrance, V Masson, J Kassis, J Fafard, M Lordkipanidzé. Study of the bioaccumulation of tinzaparin in renally impaired patients when given at prophylactic doses - The STRIP study.
Thrombosis research.
2019 02; 174(?):48-50. doi:
10.1016/j.thromres.2018.11.031. [PMID: 30554045] - Rupert Bauersachs, Agnes Y Y Lee, Pieter W Kamphuisen, Guy Meyer, Mette S Janas, Mikala F Jarner, Alok A Khorana. Renal Impairment, Recurrent Venous Thromboembolism and Bleeding in Cancer Patients with Acute Venous Thromboembolism-Analysis of the CATCH Study.
Thrombosis and haemostasis.
2018 05; 118(5):914-921. doi:
10.1055/s-0038-1641150. [PMID: 29618162] - Dana Mahmood, Bernd G Stegmayr. Haemodialysis with Tinzaparin Versus Dialysate Citrate as Anticoagulation.
Blood purification.
2018; 46(3):257-263. doi:
10.1159/000490409. [PMID: 29972824] - Linda M Hiebert. Repeated Oral or Subcutaneous LMWH Has similar Antithrombotic Activity in a Rat Venous Thrombosis Model: Antithrombotic Activity Correlates With Heparin on Endothelium When Orally Administered.
Journal of cardiovascular pharmacology and therapeutics.
2017 05; 22(3):264-272. doi:
10.1177/1074248416667601. [PMID: 27653610] - Mouna Sassi, Taher Chakroun, Elisabeth Mbemba, Patrick Van Dreden, Ismail Elalamy, Annette K Larsen, Grigoris T Gerotziafas. The Antithrombotic Potential of Tinzaparin and Enoxaparin Upon Thrombin Generation Triggered In Vitro by Human Ovarian Cancer Cells IGROV1.
Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis.
2017 Mar; 23(2):155-163. doi:
10.1177/1076029616665922. [PMID: 27609342] - Owain Thomas, Anna Larsson, Nahreen Tynngård, Ulf Schött. Thromboelastometry versus free-oscillation rheometry and enoxaparin versus tinzaparin: an in-vitro study comparing two viscoelastic haemostatic tests' dose-responses to two low molecular weight heparins at the time of withdrawing epidural catheters from ten patients after major surgery.
BMC anesthesiology.
2015 Nov; 15(?):170. doi:
10.1186/s12871-015-0145-2. [PMID: 26603039] - Annemieke Dhondt, Ruben Pauwels, Katrien Devreese, Sunny Eloot, Griet Glorieux, Raymond Vanholder. Where and When To Inject Low Molecular Weight Heparin in Hemodiafiltration? A Cross Over Randomised Trial.
PloS one.
2015; 10(6):e0128634. doi:
10.1371/journal.pone.0128634. [PMID: 26076014] - Owain Thomas, Emanuel Lybeck, Karin Strandberg, Nahreen Tynngård, Ulf Schött. Monitoring low molecular weight heparins at therapeutic levels: dose-responses of, and correlations and differences between aPTT, anti-factor Xa and thrombin generation assays.
PloS one.
2015; 10(1):e0116835. doi:
10.1371/journal.pone.0116835. [PMID: 25625201] - Dana Mahmood, Solveig Nilsson, Gunilla Olivecrona, Bernd Stegmayr. Lipoprotein lipase activity is favoured by peritoneal dialysis compared to hemodialysis.
Scandinavian journal of clinical and laboratory investigation.
2014 Jun; 74(4):296-300. doi:
10.3109/00365513.2014.882016. [PMID: 24564630] - Ming-Hsien Tsai, Yu-Wei Fang, Jyh-Gang Leu. Tinzaparin provides lower lipid profiles in maintenance hemodialysis patients: a cross-sectional observational study.
TheScientificWorldJournal.
2014; 2014(?):486781. doi:
10.1155/2014/486781. [PMID: 25489602] - Dana Mahmood, Elena Makoveichuk, Solveig Nilsson, Gunilla Olivecrona, Bernd Stegmayr. Response of angiopoietin-like proteins 3 and 4 to hemodialysis.
The International journal of artificial organs.
2014 Jan; 37(1):13-20. doi:
10.5301/ijao.5000252. [PMID: 24634330] - Bernd G Stegmayr, Per Jonsson, Dana Mahmood. A significant proportion of patients treated with citrate containing dialysate need additional anticoagulation.
The International journal of artificial organs.
2013 Jan; 36(1):1-6. doi:
10.5301/ijao.5000172. [PMID: 23280073] - Marc A Rodger, Tim Ramsay, Martin MacKinnon, Margit Westphal, Philip S Wells, Brendan McCormick, Greg Knoll. Tinzaparin versus dalteparin for periprocedure prophylaxis of thromboembolic events in hemodialysis patients: a randomized trial.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2012 Sep; 60(3):427-34. doi:
10.1053/j.ajkd.2012.01.020. [PMID: 22480794] - Linda M Hiebert, Tilly Ping, Sandra M Wice. Repeated doses of oral and subcutaneous heparins have similar antithrombotic effects in a rat carotid arterial model of thrombosis.
Journal of cardiovascular pharmacology and therapeutics.
2012 Mar; 17(1):110-6. doi:
10.1177/1074248411405991. [PMID: 21512111] - Leanne F Harris, Aoife O'Brien, Vanessa Castro-López, James S O'Donnell, Anthony J Killard. Comparison of the anticoagulant response of a novel fluorogenic anti-FXa assay with two commercial anti-FXa chromogenic assays.
Thrombosis research.
2011 Dec; 128(6):e166-70. doi:
10.1016/j.thromres.2011.08.002. [PMID: 21872908] - V Siguret, I Gouin-Thibault, E Pautas, A Leizorovicz. No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudy.
Journal of thrombosis and haemostasis : JTH.
2011 Oct; 9(10):1966-72. doi:
10.1111/j.1538-7836.2011.04458.x. [PMID: 21819539] - Vanessa Castro-López, Leanne F Harris, James S O'Donnell, Anthony J Killard. Comparative study of Factor Xa fluorogenic substrates and their influence on the quantification of LMWHs.
Analytical and bioanalytical chemistry.
2011 Jan; 399(2):691-700. doi:
10.1007/s00216-010-4314-3. [PMID: 20972772] - Mette Schroeder, John Hogwood, Elaine Gray, Barbara Mulloy, Anne-Marie Hackett, Kristian B Johansen. Protamine neutralisation of low molecular weight heparins and their oligosaccharide components.
Analytical and bioanalytical chemistry.
2011 Jan; 399(2):763-71. doi:
10.1007/s00216-010-4220-8. [PMID: 20922518] - Dana Mahmood, Maria Grubbström, Lennart D I Lundberg, Gunilla Olivecrona, Thomas Olivecrona, Bernd G Stegmayr. Lipoprotein lipase responds similarly to tinzaparin as to conventional heparin during hemodialysis.
BMC nephrology.
2010 Dec; 11(?):33. doi:
10.1186/1471-2369-11-33. [PMID: 21129229] - Nina Kerk, Elwira A Strozyk, Birgit Pöppelmann, Stefan W Schneider. The mechanism of melanoma-associated thrombin activity and von Willebrand factor release from endothelial cells.
The Journal of investigative dermatology.
2010 Sep; 130(9):2259-68. doi:
10.1038/jid.2010.136. [PMID: 20505748] - Leanne F Harris, Vanessa Castro-López, Nissrin Hammadi, James S O'Donnell, Anthony J Killard. Development of a fluorescent anti-factor Xa assay to monitor unfractionated and low molecular weight heparins.
Talanta.
2010 Jun; 81(4-5):1725-30. doi:
10.1016/j.talanta.2010.03.030. [PMID: 20441964] - Khalid A Al-Saran, Alaa Sabry, Moammer Taha, Mamdouh Abdul Ghafour, Fawzan Al Fawzan. Profile of low molecular weight tinzaparin sodium for anticoagulation during hemodialysis.
Saudi journal of kidney diseases and transplantation : an official publication of the Saudi Center for Organ Transplantation, Saudi Arabia.
2010 Jan; 21(1):43-9. doi:
NULL. [PMID: 20061691] - J-B Viguier, S Amraoui, A Solanilla, C Boulon, J Constans, C Conri. [An image of vena cava thrombosis].
Journal des maladies vasculaires.
2009 Nov; 34(5):372-3. doi:
10.1016/j.jmv.2009.07.086. [PMID: 19717254] - K Kuczka, K Baum, B Picard-Willems, S Harder. Long term administration of LMWH - pharmacodynamic parameters under therapeutic or prophylactic regimen of enoxaparin or tinzaparin in neurological rehabilitation patients.
Thrombosis research.
2009 Nov; 124(5):625-30. doi:
10.1016/j.thromres.2009.06.017. [PMID: 19625075] - NULL. Tinzaparin: excess mortality in elderly patients with renal failure. Unfractionated heparin is best in this setting.
Prescrire international.
2009 Oct; 18(103):216. doi:
NULL. [PMID: 19882795] - Alex Gatt, Joost J van Veen, Anita M Woolley, Steve Kitchen, Peter Cooper, Michael Makris. Thrombin generation assays are superior to traditional tests in assessing anticoagulation reversal in vitro.
Thrombosis and haemostasis.
2008 Aug; 100(2):350-5. doi:
10.1160/th07-05-0357. [PMID: 18690358] - Jacob A Lykke, Thor Grønlykke, Jens Langhoff-Roos. Treatment of deep venous thrombosis in pregnant women.
Acta obstetricia et gynecologica Scandinavica.
2008; 87(11):1248-51. doi:
10.1080/00016340802449118. [PMID: 18850332] - H Izzedine, P Cluzel, G Deray. Renal radiation-induced arterial stenosis.
Kidney international.
2007 Jun; 71(11):1188. doi:
10.1038/sj.ki.5002137. [PMID: 17522700] - Angelique L Rops, Cor W Jacobs, Peter C Linssen, Jan B Boezeman, Joost F Lensen, Tessa J Wijnhoven, Lambert P van den Heuvel, Toin H van Kuppevelt, Johan van der Vlag, Jo H Berden. Heparan sulfate on activated glomerular endothelial cells and exogenous heparinoids influence the rolling and adhesion of leucocytes.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2007 Apr; 22(4):1070-7. doi:
10.1093/ndt/gfl801. [PMID: 17255131] - Isabelle Mahé, Manvel Aghassarian, Ludovic Drouet, Claire Bal Dit-Sollier, Karine Lacut, Jean-Jacques Heilmann, Dominique Mottier, Jean-François Bergmann. Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study.
Thrombosis and haemostasis.
2007 Apr; 97(4):581-6. doi:
10.1160/th06-09-0513. [PMID: 17393021] - Anne Vestergård Møller, Søren Peter Jørgensen, Jian-Wen Chen, Anni Larnkjaer, Thomas Ledet, Allan Flyvbjerg, Jan Frystyk. Glycosaminoglycans increase levels of free and bioactive IGF-I in vitro.
European journal of endocrinology.
2006 Aug; 155(2):297-305. doi:
10.1530/eje.1.02203. [PMID: 16868144] - S A Mousa. Elevation of plasma von Willebrand factor and tumor necrosis factor-a in obese subjects and their reduction by the low molecular weight heparin tinzaparin.
International angiology : a journal of the International Union of Angiology.
2005 Sep; 24(3):278-81. doi:
NULL. [PMID: 16158039] - F N Christidou, T K Frangia, G I Bamichas, L C Gionanlis, T A Natse, I E Georgoulis, K I Sombolos. Comparison of two low-molecular weight heparins (LMWHs), tinzaparin and bemiparin, during hemodialysis.
International journal of clinical pharmacology and therapeutics.
2005 Jul; 43(7):335-8. doi:
10.5414/cpp43335. [PMID: 16035376] - S A Mousa, K Johansen. Pharmacodynamic effects of low molecular weight heparin in obese subjects following subcutaneous administration of 75 IU/kg on plasma tissue factor pathway inhibitor and nitric oxide.
International angiology : a journal of the International Union of Angiology.
2005 Mar; 24(1):40-2. doi:
NULL. [PMID: 15876997] - Jonas Angel Sjøland, Robert Smith Pedersen, Jørgen Jespersen, Jørgen Gram. Intraperitoneal heparin ameliorates the systemic inflammatory response in PD patients.
Nephron. Clinical practice.
2005; 100(4):c105-10. doi:
10.1159/000085289. [PMID: 15849476] - M Florian-Kujawski, D Hoppensteadt, J Maddineni, H Ziegler, J Fareed. Differential regulation of thrombin activatable fibrinolytic inhibitor by low molecular weight heparins. Pharmacologic implications.
International angiology : a journal of the International Union of Angiology.
2004 Dec; 23(4):346-54. doi:
NULL. [PMID: 15767980] - Linda M Hiebert, Sandra M Wice, Tilly Ping. Tissue distribution of the low molecular weight heparin, tinzaparin, following administration to rats by the oral route.
Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.
2004 Jul; 58(6-7):372-80. doi:
10.1016/j.biopha.2004.02.006. [PMID: 15271419] - Cory Pinel, Sandra M Wice, Linda M Hiebert. Orally administered heparins prevent arterial thrombosis in a rat model.
Thrombosis and haemostasis.
2004 May; 91(5):919-26. doi:
10.1160/th03-08-0527. [PMID: 15116252] - Jonas Angel Sjøland, Robert Smith Pedersen, Jørgen Jespersen, Jørgen Gram. Intraperitoneal heparin reduces peritoneal permeability and increases ultrafiltration in peritoneal dialysis patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
2004 May; 19(5):1264-8. doi:
10.1093/ndt/gfh065. [PMID: 14993509] - Walter Jeske, Jawed Fareed. Pharmacodynamic considerations in the selection of dosage of tinzaparin for various indications: experimental studies in primates.
Seminars in thrombosis and hemostasis.
2004 Feb; 30 Suppl 1(?):41-7. doi:
10.1055/s-2004-823002. [PMID: 15085465] - Shaker A Mousa, Jeffrey Bozarth, Jeffrey S Barrett. Pharmacodynamic properties of the low molecular weight heparin, tinzaparin: effect of molecular weight distribution on plasma tissue factor pathway inhibitor in healthy human subjects.
Journal of clinical pharmacology.
2003 Jul; 43(7):727-34. doi:
10.1177/0091270003254793. [PMID: 12856386] - Evangelos Sarris, Efrosini Tsele, Giorgia Bagiatoudi, Konstantinos Salpigidis, Danai Stavrianaki, Loukas Kaklamanis, Marios Siakotos. Diffuse alopecia in a hemodialysis patient caused by a low-molecular-weight heparin, tinzaparin.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2003 May; 41(5):E15. doi:
10.1016/s0272-6386(03)00211-7. [PMID: 12778433] - S Chan, M Kong, D M Minning, U Hedner, V J Marder. Assessment of recombinant factor VIIa as an antidote for bleeding induced in the rabbit by low molecular weight heparin.
Journal of thrombosis and haemostasis : JTH.
2003 Apr; 1(4):760-5. doi:
10.1046/j.1538-7836.2003.00101.x. [PMID: 12871413] - F Depasse, M J González de Suso, I Lagoutte, J Fontcuberta, M Borrell, M M Samama. Comparative study of the pharmacokinetic profiles of two LMWHs--bemiparin (3500 IU, anti-Xa) and tinzaparin (4500 IU, anti-Xa)--administered subcutaneously to healthy male volunteers.
Thrombosis research.
2003 Jan; 109(2-3):109-17. doi:
10.1016/s0049-3848(03)00141-5. [PMID: 12706639] - Jeff Nagge, Mark Crowther, Jack Hirsh. Is impaired renal function a contraindication to the use of low-molecular-weight heparin?.
Archives of internal medicine.
2002 Dec; 162(22):2605-9. doi:
10.1001/archinte.162.22.2605. [PMID: 12456233] - James W Hainer, Donald J Sherrard, Suzanne K Swan, Jeffrey S Barrett, Christopher A Assaid, Michael J Fossler, Donna S Cox, Robert M Williams, Amy L Pittenger, Carol A Stephenson, Tsushung A Hua. Intravenous and subcutaneous weight-based dosing of the low molecular weight heparin tinzaparin (Innohep) in end-stage renal disease patients undergoing chronic hemodialysis.
American journal of kidney diseases : the official journal of the National Kidney Foundation.
2002 Sep; 40(3):531-8. doi:
10.1053/ajkd.2002.34911. [PMID: 12200805] - C E Geffroy, E Couffin, J Doucet, P Carvalho, L Sibert, C Bentot, D Mouton-Schleifer, H Lévesque, Ph Chassagne, E Bercoff. [Inappropriate prescription of heparin at curative doses in the hospital. Can the information to prescribing physicians decrease misuse?].
Presse medicale (Paris, France : 1983).
2002 Feb; 31(7):303-11. doi:
NULL. [PMID: 11899684] - Eric Pautas, Isabelle Gouin, Oliver Bellot, Jean-Paul Andreux, Virginie Siguret. Safety profile of tinzaparin administered once daily at a standard curative dose in two hundred very elderly patients.
Drug safety.
2002; 25(10):725-33. doi:
10.2165/00002018-200225100-00005. [PMID: 12167068] - J Ellison, A J Thomson, J A Conkie, F McCall, D Walker, A Greer. Thromboprophylaxis following caesarean section--a comparison of the antithrombotic properties of three low molecular weight heparins--dalteparin, enoxaparin and tinzaparin.
Thrombosis and haemostasis.
2001 Dec; 86(6):1374-8. doi:
NULL. [PMID: 11776302] - J S Barrett, E Gibiansky, R D Hull, A Planès, H Pentikis, J W Hainer, T A Hua, M Gastonguay. Population pharmacodynamics in patients receiving tinzaparin for the prevention and treatment of deep vein thrombosis.
International journal of clinical pharmacology and therapeutics.
2001 Oct; 39(10):431-46. doi:
10.5414/cpp39431. [PMID: 11680668] - J S Barrett, J W Hainer, D M Kornhauser, J L Gaskill, T A Hua, P Sprogel, K Johansen, J J van Lier, W Knebel, H J Pieniaszek. Anticoagulant pharmacodynamics of tinzaparin following 175 iu/kg subcutaneous administration to healthy volunteers.
Thrombosis research.
2001 Feb; 101(4):243-54. doi:
10.1016/s0049-3848(00)00412-6. [PMID: 11248285] - E Pautas, V Siguret, M d'Urso, M Laurent, P Gaussem, M Février, B Durand-Gasselin. [Monitoring of tinzaparin in a ten day treatment dose in elderly patients].
La Revue de medecine interne.
2001 Feb; 22(2):120-6. doi:
10.1016/s0248-8663(00)00301-5. [PMID: 11234669] - V Siguret, E Pautas, M Février, C Wipff, B Durand-Gasselin, M Laurent, J P Andreux, M d'Urso, P Gaussem. Elderly patients treated with tinzaparin (Innohep) administered once daily (175 anti-Xa IU/kg): anti-Xa and anti-IIa activities over 10 days.
Thrombosis and haemostasis.
2000 Nov; 84(5):800-4. doi:
10.1055/s-0037-1614119. [PMID: 11127859] - L Bara, A Planes, M M Samama. Occurrence of thrombosis and haemorrhage, relationship with anti-Xa, anti-IIa activities, and D-dimer plasma levels in patients receiving a low molecular weight heparin, enoxaparin or tinzaparin, to prevent deep vein thrombosis after hip surgery.
British journal of haematology.
1999 Feb; 104(2):230-40. doi:
10.1046/j.1365-2141.1999.01153.x. [PMID: 10050702] - M Hasan, S Najjam, M Y Gordon, R V Gibbs, C C Rider. IL-12 is a heparin-binding cytokine.
Journal of immunology (Baltimore, Md. : 1950).
1999 Jan; 162(2):1064-70. doi:
NULL. [PMID: 9916734] - S Nielsen, A Schmitz, T Bacher, M Rehling, J Ingerslev, C E Mogensen. Transcapillary escape rate and albuminuria in Type II diabetes. Effects of short-term treatment with low-molecular weight heparin.
Diabetologia.
1999 Jan; 42(1):60-7. doi:
10.1007/s001250051114. [PMID: 10027580] - P Martineau, N Tawil. Low-molecular-weight heparins in the treatment of deep-vein thrombosis.
The Annals of pharmacotherapy.
1998 May; 32(5):588-98, 601. doi:
10.1345/aph.16450. [PMID: 9606481] - C D Fegan. Tinzaparin as an antithrombotic: an overview.
Hospital medicine (London, England : 1998).
1998 Feb; 59(2):145-8. doi:
NULL. [PMID: 9797891] - J Holst, B Lindblad, D Bergqvist, U Hedner, O Nordfang, P Ostergaard. The effect of protamine sulphate on plasma tissue factor pathway inhibitor released by intravenous and subcutaneous unfractionated and low molecular weight heparin in man.
Thrombosis research.
1997 May; 86(4):343-8. doi:
10.1016/s0049-3848(97)00078-9. [PMID: 9187023] - J M Muir, J Hirsh, J I Weitz, M Andrew, E Young, S G Shaughnessy. A histomorphometric comparison of the effects of heparin and low-molecular-weight heparin on cancellous bone in rats.
Blood.
1997 May; 89(9):3236-42. doi:
10.1182/blood.v89.9.3236. [PMID: 9129028] - H K Simpson, J Baird, M Allison, J D Briggs, P A Rowe, M Welsh, A I Macdougall, A C Grant, G D Lowe, A Rumley, M Wallace, A P Menday. Long-term use of the low molecular weight heparin tinzaparin in haemodialysis.
Haemostasis.
1996 Mar; 26(2):90-7. doi:
10.1159/000217193. [PMID: 9119288] - H A Friedel, J A Balfour. Tinzaparin. A review of its pharmacology and clinical potential in the prevention and treatment of thromboembolic disorders.
Drugs.
1994 Oct; 48(4):638-60. doi:
10.2165/00003495-199448040-00010. [PMID: 7528134] - P B Johansen, S N Rasmussen, P B Ostergaard. Pharmacokinetics of tinzaparin (Logiparin)--a low molecular weight heparin--after single and repeated intravenous administration in rats.
Thrombosis research.
1994 Aug; 75(4):453-64. doi:
10.1016/0049-3848(94)90260-7. [PMID: 7997983] - C J Brindley, T Taylor, V Diness, P B Oestergaard, L F Chasseaud. Relationship between pharmacokinetics and pharmacodynamics of tinzaparin (logiparin), a low molecular weight heparin, in dogs.
Xenobiotica; the fate of foreign compounds in biological systems.
1993 Jun; 23(6):575-88. doi:
10.3109/00498259309059396. [PMID: 8212732]